Alzheimer's Disease Archives - Insights Get the latest news and education from Mayo Clinic Laboratories Thu, 30 Oct 2025 14:48:48 +0000 en-US hourly 1 https://wordpress.org/?v=6.8.3 Join us on Oct. 29 for a SAAmplify-αSYN testing webinar https://news.mayocliniclabs.com/2025/09/08/join-us-on-oct-29-for-a-saamplify-%ce%b1syn-testing-webinar/ https://news.mayocliniclabs.com/2025/09/08/join-us-on-oct-29-for-a-saamplify-%ce%b1syn-testing-webinar/#respond Mon, 08 Sep 2025 13:00:00 +0000 https://news.mayocliniclabs.com/?p=118036 Join us on Oct. 29 for a SAAmplify-αSYN testing webinarJoin us for a webinar exploring the revolutionary way SAAmplify™–αSYN testing, which is offered by Mayo Clinic Laboratories in collaboration with Amprion, is improving diagnostic accuracy for patients with neurodegenerative disorders.

The post Join us on Oct. 29 for a SAAmplify-αSYN testing webinar appeared first on Insights.

]]> https://news.mayocliniclabs.com/2025/09/08/join-us-on-oct-29-for-a-saamplify-%ce%b1syn-testing-webinar/feed/ 0 Alzheimer’s Disease: Understanding CSF Biomarkers https://news.mayocliniclabs.com/2025/09/03/alzheimers-disease-understanding-csf-biomarkers/ https://news.mayocliniclabs.com/2025/09/03/alzheimers-disease-understanding-csf-biomarkers/#respond Wed, 03 Sep 2025 10:00:00 +0000 https://news.mayocliniclabs.com/?p=118039 Alzheimer’s Disease: Understanding CSF BiomarkersDiagnostic advances allow earlier & more accurate detection of Alzheimer's using cerebrospinal fluid biomarkers.

The post Alzheimer’s Disease: Understanding CSF Biomarkers appeared first on Insights.

]]> https://news.mayocliniclabs.com/2025/09/03/alzheimers-disease-understanding-csf-biomarkers/feed/ 0 The Promise, Challenges, and Global Impact of AI Tools: Bill Morice, M.D., Ph.D. https://news.mayocliniclabs.com/2025/08/14/the-promise-challenges-and-global-impact-of-ai-tools-bill-morice-m-d-ph-d/ https://news.mayocliniclabs.com/2025/08/14/the-promise-challenges-and-global-impact-of-ai-tools-bill-morice-m-d-ph-d/#respond Thu, 14 Aug 2025 13:00:00 +0000 https://news.mayocliniclabs.com/?p=117845 The Promise, Challenges, and Global Impact of AI Tools: Bill Morice, M.D., Ph.D.In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, discuss recent news about the use of artificial intelligence (AI) tools in healthcare.

The post The Promise, Challenges, and Global Impact of AI Tools: Bill Morice, M.D., Ph.D. appeared first on Insights.

]]> https://news.mayocliniclabs.com/2025/08/14/the-promise-challenges-and-global-impact-of-ai-tools-bill-morice-m-d-ph-d/feed/ 0 Revolutionary Technology Advances Diagnosis of Neurodegenerative Disorders: Bill Morice, M.D., Ph.D. https://news.mayocliniclabs.com/2025/04/24/revolutionary-technology-advances-diagnosis-of-neurodegenerative-disorders-bill-morice-m-d-ph-d/ https://news.mayocliniclabs.com/2025/04/24/revolutionary-technology-advances-diagnosis-of-neurodegenerative-disorders-bill-morice-m-d-ph-d/#respond Thu, 24 Apr 2025 13:00:00 +0000 https://news.mayocliniclabs.com/?p=116101 Revolutionary Technology Advances Diagnosis of Neurodegenerative Disorders: Bill Morice, M.D., Ph.D.In this episode of “Answers From the Lab,” William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, is joined by Russ Lebovitz, M.D., Ph.D., CEO and co-founder of Amprion. They discuss their strategic collaboration and the innovative SAAmplify™–αSYN (CSF) test.

The post Revolutionary Technology Advances Diagnosis of Neurodegenerative Disorders: Bill Morice, M.D., Ph.D. appeared first on Insights.

]]> https://news.mayocliniclabs.com/2025/04/24/revolutionary-technology-advances-diagnosis-of-neurodegenerative-disorders-bill-morice-m-d-ph-d/feed/ 0 Mayo Clinic Laboratories and Amprion announce collaboration to advance neurodegenerative disease diagnostics https://news.mayocliniclabs.com/2025/03/26/mayo-clinic-laboratories-and-amprion-announce-collaboration-to-advance-neurodegenerative-disease-diagnostics/ https://news.mayocliniclabs.com/2025/03/26/mayo-clinic-laboratories-and-amprion-announce-collaboration-to-advance-neurodegenerative-disease-diagnostics/#respond Wed, 26 Mar 2025 14:00:00 +0000 https://news.mayocliniclabs.com/?p=115573 Mayo Clinic Laboratories and Amprion announce collaboration to advance neurodegenerative disease diagnosticsMayo Clinic Laboratories and Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, today announced a collaboration to expand access to Amprion's SAAmplify–αSYN (CSF) test across the United States. The test (test ID ASYNC) is available today for clients of Mayo Clinic Laboratories through the collaboration that combines the expertise of both organizations to enhance patient care and improve diagnostic accuracy for neurodegenerative diseases.

The post Mayo Clinic Laboratories and Amprion announce collaboration to advance neurodegenerative disease diagnostics appeared first on Insights.

]]> https://news.mayocliniclabs.com/2025/03/26/mayo-clinic-laboratories-and-amprion-announce-collaboration-to-advance-neurodegenerative-disease-diagnostics/feed/ 0 New test distinguishes between prion disease and other causes of rapidly progressive dementia https://news.mayocliniclabs.com/2025/02/03/new-test-distinguishes-between-prion-disease-and-other-causes-of-rapidly-progressive-dementia/ https://news.mayocliniclabs.com/2025/02/03/new-test-distinguishes-between-prion-disease-and-other-causes-of-rapidly-progressive-dementia/#respond Mon, 03 Feb 2025 14:00:00 +0000 https://news.mayocliniclabs.com/?p=114501 New test distinguishes between prion disease and other causes of rapidly progressive dementiaPerformed on cerebrospinal fluid, Mayo Clinic’s RT-QuIC prion test can distinguish prion disease from other types of rapidly progressive dementias to enhance patient care.

The post New test distinguishes between prion disease and other causes of rapidly progressive dementia appeared first on Insights.

]]> https://news.mayocliniclabs.com/2025/02/03/new-test-distinguishes-between-prion-disease-and-other-causes-of-rapidly-progressive-dementia/feed/ 0 Plasma Test Increases Access to Alzheimer’s Testing: Alicia Algeciras-Schimnich, Ph.D. https://news.mayocliniclabs.com/2024/10/10/plasma-test-increases-access-to-alzheimers-testing-alicia-algeciras-schimnich-ph-d/ https://news.mayocliniclabs.com/2024/10/10/plasma-test-increases-access-to-alzheimers-testing-alicia-algeciras-schimnich-ph-d/#respond Thu, 10 Oct 2024 13:00:00 +0000 https://news.mayocliniclabs.com/?p=112930 Plasma Test Increases Access to Alzheimer’s Testing: Alicia Algeciras-Schimnich, Ph.D.In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Alicia Algeciras-Schimnich, Ph.D., a professor of laboratory medicine and pathology at Mayo Clinic and co-director of the Clinical Immunoassay Laboratory. They discuss Mayo Clinic’s plasma test for detecting Alzheimer’s disease and how […]

The post Plasma Test Increases Access to Alzheimer’s Testing: Alicia Algeciras-Schimnich, Ph.D. appeared first on Insights.

]]> https://news.mayocliniclabs.com/2024/10/10/plasma-test-increases-access-to-alzheimers-testing-alicia-algeciras-schimnich-ph-d/feed/ 0 Breakthrough Lab Tests for Detecting Alzheimer’s Disease: Bill Morice, M.D., Ph.D. https://news.mayocliniclabs.com/2024/09/05/breakthrough-lab-tests-for-detecting-alzheimers-disease-bill-morice-m-d-ph-d/ https://news.mayocliniclabs.com/2024/09/05/breakthrough-lab-tests-for-detecting-alzheimers-disease-bill-morice-m-d-ph-d/#respond Thu, 05 Sep 2024 13:00:00 +0000 https://news.mayocliniclabs.com/?p=112464 Breakthrough Lab Tests for Detecting Alzheimer’s Disease: Bill Morice, M.D., Ph.D.In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss the latest advancements in Alzheimer’s disease testing and treatment.

The post Breakthrough Lab Tests for Detecting Alzheimer’s Disease: Bill Morice, M.D., Ph.D. appeared first on Insights.

]]> https://news.mayocliniclabs.com/2024/09/05/breakthrough-lab-tests-for-detecting-alzheimers-disease-bill-morice-m-d-ph-d/feed/ 0 Alzheimer’s Disease 2024: The Role of Biomarkers https://news.mayocliniclabs.com/2024/06/17/alzheimers-disease-2024-the-role-of-biomarkers/ https://news.mayocliniclabs.com/2024/06/17/alzheimers-disease-2024-the-role-of-biomarkers/#respond Mon, 17 Jun 2024 10:00:00 +0000 https://news.mayocliniclabs.com/?p=111608 Alzheimer’s Disease 2024: The Role of BiomarkersPACE/State of FL - The latest updates in Alzheimer’s disease diagnostic criteria as well as a comprehensive review of the laboratory testing landscape.

The post Alzheimer’s Disease 2024: The Role of Biomarkers appeared first on Insights.

]]> https://news.mayocliniclabs.com/2024/06/17/alzheimers-disease-2024-the-role-of-biomarkers/feed/ 0 New Panels Help Find Cause of Rapidly Progressive Dementia: Gregg Day, M.D. https://news.mayocliniclabs.com/2024/05/14/new-panels-help-find-cause-of-rapidly-progressive-dementia-greggory-gregg-day-m-d/ https://news.mayocliniclabs.com/2024/05/14/new-panels-help-find-cause-of-rapidly-progressive-dementia-greggory-gregg-day-m-d/#respond Tue, 14 May 2024 13:00:00 +0000 https://news.mayocliniclabs.com/?p=106059 New Panels Help Find Cause of Rapidly Progressive Dementia: Gregg Day, M.D.Rapidly progressive dementia (RPD) is an umbrella term covering many devasting conditions, including Creutzfeldt-Jakob disease (CJD). Gregory (Gregg) Day, M.D., explains how Mayo Clinic Laboratories' unique RPD evaluation and new CJD test help pinpoint diagnosis, to guide prognosis and treatment decisions.

The post New Panels Help Find Cause of Rapidly Progressive Dementia: Gregg Day, M.D. appeared first on Insights.

]]> https://news.mayocliniclabs.com/2024/05/14/new-panels-help-find-cause-of-rapidly-progressive-dementia-greggory-gregg-day-m-d/feed/ 0